K. Bennett

发表

cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.

L. Madisen, G. Plowman, A. Purchio, 1992, DNA and cell biology.

Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44

D. Taub, A. Aruffo, W. Murphy, 1999, The Journal of Biological Chemistry.

and in normal cornea proteoglycans in Maroteaux-Lamy syndrome type B expression of ßig-h3 and keratan sulphate Clinical and morphological features including

S. Akhtar, B. Caterson, A. Tullo, 2005 .

The extracellular matrix protein βIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion

R. Kramer, B. Thoma, R. LeBaron, 2003, Cell and Tissue Research.

Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.

R. Storb, B. Sandmaier, F. Appelbaum, 1998, Blood.

Beta-ig. Molecular cloning and in situ hybridization in corneal tissues.

C. Cintron, I. Rawe, K. Bennett, 1997, Investigative ophthalmology & visual science.

βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions

T. Zderic, M. Nobuyoshi, Takeshi Kimura, 1996 .

Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea

S. Akhtar, K. Meek, B. Caterson, 2002, The British journal of ophthalmology.

P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153: Topic: IT

E. Stepanski, D. Spigel, D. Waterhouse, 2017 .

Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions.

T. Zderic, M. Nobuyoshi, S. Schwartz, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Potential immune biomarkers of gastrointestinal toxicities and efficacy in patients with advanced melanoma treated with ipilimumab with or without prophylactic budesonide

S. Chasalow, Z. Tsuchihashi, S. Galbraith, 2008 .

cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β

L. Madisen, G. Plowman, A. Purchio, 1992 .

Immunolocalization of (cid:98) ig-h3 Protein in 5q31-Linked Corneal Dystrophies and Normal Corneas

R. Eagle, Ye Qi, Y. Qi, 1999 .

Immunolocalization of beta ig-h3 protein in 5q31-linked corneal dystrophies and normal corneas.

R. Eagle, Y. Qi, B. Streeten, 1999, Archives of ophthalmology.

Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas.

C. Cintron, G. Klintworth, K. Hirano, 1996, Current eye research.

Congenital Hereditary Endothelial Dystrophy and Band Keratopathy in an Infant With Corpus Callosum Agenesis

Kelly Bennett, A. Bron, S. Akhtar, 2001, Cornea.

Epitope Specificity of CD44 for Monoclonal Antibody–Dependent Facilitation of Marrow Engraftment in a Canine Model

R. Storb, B. Sandmaier, F. Appelbaum, 1998 .

Amyloid and Pro501 Thr-mutated (beta)ig-h3 gene product colocalize in lattice corneal dystrophy type IIIA.

A. Quantock, A. Dota, S. Kinoshita, 1999, American journal of ophthalmology.

Characterization of the Heparan Sulfate and Chondroitin Sulfate Assembly Sites in CD44*

A. Aruffo, H. Marquardt, M. Piepkorn, 1999, The Journal of Biological Chemistry.

βig-h3: A Transforming Growth Factor-β-Responsive Gene Encoding a Secreted Protein That Inhibits Cell Attachment In Vitro and Suppresses the Growth of CHO Cells in Nude Mice

Hans Marquardt, C. Disteche, S. Edelhoff, 1994 .

beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice.

C. Disteche, S. Edelhoff, G. Plowman, 1994, DNA and cell biology.

Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549.

G. Plowman, A. Purchio, S. Buckley, 1992, Growth factors.

A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors.

Lixin Lang, S. Alberts, K. Papadopoulos, 2010 .

Colocalization of basic fibroblast growth factor and CD44 isoforms containing the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin cancers

K. Bennett, J. Simon, A. Aruffo, 1999, The British journal of dermatology.

Deleted in Colorectal Carcinoma (DCC) Binds Heparin via Its Fifth Fibronectin Type III Domain*

K. Bennett, P. Linsley, J. Bradshaw, 1997, The Journal of Biological Chemistry.

Abstract A55: A first‐in‐human, phase I study of an oral hedgehog pathway antagonist, BMS‐833923 (XL139), in subjects with advanced or metastatic solid tumors

A. Tolcher, Lixin Lang, S. Alberts, 2009 .

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

K. Bennett, I. Stamenkovic, D. Jackson, 1995, The Journal of cell biology.

Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.

K. Bennett, P. Linsley, J. Bradshaw, 1996, Immunity.

Ipilimumab (IPI) Expanded Access Program (EAP) for Patients (PTS) with Stage III/IV Melanoma: Safety Data by Subgroups

J. Wolchok, F. Hodi, D. Lawrence, 2012 .

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

I. Stamenkovic, B. Modrell, G. Plowman, 1995, The Journal of cell biology.

A Phase I Study of An Oral Hedgehog Pathway Antagonist, BMS-833923, in Patients with Relapsed or Refractory Multiple Myeloma,

C. Huff, Lixin Lang, L. Camacho, 2011 .

Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.

W. Urba, H. Kaufman, D. McDermott, 2013 .

Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea

S. Akhtar, K. Meek, B. Caterson, 2002, The British journal of ophthalmology.